Why did Sigma Healthcare decide not to pursue the acquisition of Boots?

Sigma Healthcare dropped its pursuit of UK pharmacy chain Boots because, after an initial review, it concluded that a potential deal 'would not meet its strategic and capital investment objectives.' Although it had considered the opportunity as a way to accelerate its expansion in the United Kingdom through Boots' established brand and extensive footprint, the company ultimately determined the acquisition was misaligned with its core strategic and financial goals.

What is Sigma Healthcare's stated stance on international growth following the decision to walk away from Boots?

Sigma Healthcare reaffirmed that 'international growth remains one of its key strategic pillars' and reiterated its commitment to expanding in 'core offshore markets' while also exploring opportunities in 'new regions'—a statement made despite abandoning the Boots acquisition, underscoring that its broader international strategy remains intact and active.

Australia's Sigma Healthcare Drops Pursuit of UK Pharmacy Chain Boots

Jun 14, 2026

Sigma Healthcare terminated preliminary talks to acquire UK pharmacy chain Boots, stating the deal would not meet its strategic and capital investment objectives.

reuters

2026-06-09

Boots Enters Talks for $10 Billion Sale, Scraps London IPO Plans

2026-06-14

Australia's Sigma Healthcare Drops Pursuit of UK Pharmacy Chain Boots

2026-10-01

Boots Owner Closing In on Sale to Canada’s Weston Family for $9bn

Australia's Sigma Healthcare Drops Pursuit of UK Pharmacy Chain Boots

FAQ